IL-12 and IL-27 regulate the phagolysosomal pathway in mycobacteria- infected human macrophages

Cell Communication and Signaling

Volumn 12, Issue 1, 2014, Pages

  Jung, Joo Yong ^a   Robinson, Cory M ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

BCG; Cathepsin D; CD63; Human macrophages; Phagolysosome; V ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CATHEPSIN D; CD63 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 27; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; VACUOLAR ADENOSINE TRIPHOSPHATASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ACIDIFICATION; ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ARTICLE; BACTERIAL GROWTH; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; INFECTION CONTROL; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MACROPHAGE; MACROPHAGE FUNCTION; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; PHAGOLYSOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; ADOLESCENT; ADULT; DRUG EFFECT; LYSOSOME; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PH; PHAGOSOME;

ADOLESCENT; ADULT; ANTIGENS, CD63; CATHEPSIN D; HUMANS; HYDROGEN-ION CONCENTRATION; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-27; LYSOSOMES; MACROPHAGES; MYCOBACTERIUM BOVIS; PHAGOSOMES; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 84898431328     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-12-16     Document Type: Article

References (46)

1. Global tuberculosis report 2012. [ http://www.who.int/tb/publications/ global-report/en/ ]
2. Immune responses to tuberculosis in developing countries: implications for new vaccines. Rook GAW, Dheda K, Zumla A, Nat Rev Immunol 2005 5 661 667 10.1038/nri1666 16056257 (Pubitemid 41113197)
3. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life: final report to the Medical Research Council. Hart PD, Sutherland I, BMJ 1977 2 293 295 10.1136/bmj.2.6082.293 326347 (Pubitemid 8153940)
4. Fine PEM, Carneiro IAM, Milstien JB, Clements JD, Issues relating to the Use of BCG in Immunization Programs: a Discussion Document. Document WHO/V&B/99.23 Geneva, Switzerland: World Health Organization Department of Vaccines and Biologicals 1999
5. Iron-cofactored superoxide dismutase inhibits host response to Mycobacterium tuberculosis. Edwards KM, Cynamon MH, Voladri RK, Hager CC, Destefano MS, Tham KT, Lakey DL, Bochan MR, Kernodle DS, Am J Respir Crit Care Med 2001 164 2213 2219 10.1164/ajrccm.164.12.2106093 11751190 (Pubitemid 34032938)
6. The SecA2 secretion factor of Mycobacterium tuberculosis promotes growth in macrophages and inhibits host immune response. Kurtz S, McKinnon KP, Runge MS, Ting JP, Braunstein M, Infect Immun 2006 74 6855 6864 10.1128/IAI.01022-06 17030572 (Pubitemid 44913161)
7. Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice. Biet F, Kremer L, Wolowczuk I, Declacre M, Locht C, Infect Immun 2002 70 6549 6557 10.1128/IAI.70.12.6549-6557.2002 12438324 (Pubitemid 35387880)
8. Immunotherapeutics for tuberculosis in experimental animals: is there a common pathway activated by effective protocols? Rook GAW, Lowrie DB, Hernandez-Pando R, J Infect Dis 2007 196 191 198 10.1086/518937 17570105 (Pubitemid 47047457)
9. Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27. Beadling C, Slifka MK, Arch Immunol Ther Exp 2006 54 15 24 10.1007/s00005-006-0002-6 (Pubitemid 44124218)
10. Interleukin 27: a double-edged sword for offense and defense. Yoshida H, Nakaya M, Miyazaki Y, J Leukoc Biol 2009 86 1295 1303 10.1189/jlb.0609445 19801497
11. IL-27, a heterodimeric cytokine composed of EBI3 and P28 protein, induces proliferation of naïve CD4+ T cells. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E, Blumenschein WM, Mattson JD, Wagner JL, To W, Zurawski S, McClanahan TK, Gorman DM, Bazan JF, de Waal Malefyt R, Rennick D, Kastelein RA, Immun 2002 16 779 790 10.1016/S1074-7613(02)00324-2 (Pubitemid 34786477)
12. The regulation of inflammation by interferons and their STATs. Rauch I, Mller M, Decker T, JAK-STAT 2013 2 23820 10.4161/jkst.23820 24058799
13. Advances in understanding the anti-inflammatory properties of IL-27. Stumhofer JS, Hunter CA, Immunol Lett 2008 117 123 130 10.1016/j.imlet.2008.01. 011 18378322
14. Induction of regulatory Tr1 cells and inhibition of TH 17cells by IL-27. Pot C, Apetoch L, Awasthi A, Kuchroo VK, Semin Immunol 2011 23 438 445 10.1016/j.smim.2011.08.003 21893418
15. IL-27 renders DC immunosuppressive by induction of B7-H1. Karakhanova S, Bedke T, Enk AH, Mahneke K, J Leukoc Biol 2011 89 837 845 10.1189/jlb.1209788 21345970
16. IL-27 production and STAT-3 dependent upregulation of B7-H1 mediate immune regulatory functions of liver plasmacytoid dendritic cells. Matta BM, Raimondi G, Rosborough BR, Sumpter TL, Thomson AW, J Immunol 2012 188 5227 5237 10.4049/jimmunol.1103382 22508931
17. Interleukin-12 and interleukin-27 regulate macrophage control of Mycobacterium tuberculosis. Robinson CM, Nau GJ, J Infect Dis 2008 198 359 366 10.1086/589774 18557702
18. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. Holscher C, HÖlscher A, Rückerl D, Yoshimoto T, Yoshida H, Mak T, Saris C, Ehlers S, J Immunol 2005 174 3534 3544 15749890 (Pubitemid 40354062)
19. Interferon-γ, tumornecrosis factor, and interleukin-18 cooperate to control growth of Mycobacterium tuberculosis in human macrophages. Robinson CM, Jung JY, Nau GJ, Cytokine 2012 60 233 241 10.1016/j.cyto.2012.06.012 22749533
20. Cytokines involved in interferon-γ production by human macrophages. Robinson CM, O'Dee D, Hamilton T, Nau GJ, J Innate Immun 2010 2 56 65 10.1159/000247156 20375623
21. Interleukin-27 inhibits phagosomal acidification by blocking vacuolar ATPases. Jung JY, Robinson CM, Cytokine 2013 62 202 205 10.1016/j.cyto.2013.03. 010 23557795
22. Cell biology of Mycobacterium tuberculosis phagosome. Vergne I, Chua J, Singh SB, Deretic V, Annu Rev Cell Dev Biol 2004 20 367 394 10.1146/annurev. cellbio.20.010403.114015 15473845 (Pubitemid 39488643)
23. Effects of cytokines on mycobacterial phagosome maturation. Via LE, Fratti RA, McFalone M, Pagan-Ramos E, Deretic D, Deretic V, J Cell Sci 1998 111 897 905 9490634 (Pubitemid 28196073)
24. Induction of p38 mitogen-activated protein kinase reduces early endosome autoantigen 1 (EEA1) recruitment to phagosomal membranes. Fratti RA, Chua J, Deretic V, J Biol Chem 2003 278 46961 46967 10.1074/jbc.M305225200 12963735 (Pubitemid 37452278)
25. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Fratti RA, Chua J, Vergne I, Deretic V, Proc Natl Acad Sci USA 2003 100 5437 5442 10.1073/pnas.0737613100 12702770 (Pubitemid 36542723)
26. Type1 and type2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-γ or IL-10. Montaner LJ, da Silva RP, Sun J, Sutterwala S, Hollinshead M, Vaux D, Gordon S, J Immunol 1999 162 4606 4613 10202000 (Pubitemid 29314860)
27. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. Clemens DL, Horwitz MA, J Exp Med 1995 181 257 270 10.1084/jem.181.1.257 7807006
28. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Forgac M, Nat Rev Mol Cell Biol 2007 8 917 929 10.1038/nrm2272 17912264 (Pubitemid 47622561)
29. Cathepsin D-Many functions of one aspartic protease. Benes P, Vetvicka V, Fusek M, Crit Rev Oncol Hematol 2008 68 12 28 10.1016/j.critrevonc.2008.02.008 18396408
30. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Sturgill-Koszycki S, Schlesinger PH, Chakraborty P, Haddix PL, Collins HL, Fok AK, Allen RD, Gluck SL, Heuser J, Russell DG, Science 1994 263 678 681 10.1126/science.8303277 8303277
31. +-ATPase to inhibit phagosome acidification. Wong D, Bach H, Sun J, Hmama Z, Av-Gay Y, Proc Natl Acad Sci USA 2011 108 19371 19376 10.1073/pnas.1109201108 22087003
32. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation. Nakagawa TY, Rudensky AY, Immunol Rev 1999 172 121 129 10.1111/j.1600-065X.1999.tb01361.x 10631942 (Pubitemid 30000474)
33. Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. Sturgill-Koszycki S, Schaible UE, Russell DG, EMBO J 1996 15 6960 6968 9003772 (Pubitemid 27023267)
34. Metabolic products of microorganisms.224. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity. Werner G, Hagenmaier H, Drautz H, Baumgatner A, Zähner H, J Antibiot 1984 37 110 117 10.7164/antibiotics.37.110 6423597 (Pubitemid 14195336)
35. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Bowman EJ, Siebers A, Altendorf K, Proc Natl Acad Sci USA 1988 85 7972 7976 10.1073/pnas.85.21.7972 2973058
36. Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition. Rich DH, Bernatowicz MS, Agarwal NS, Kawai M, Salituro FG, Schmidt PG, Biochemistry 1985 24 3165 3173 10.1021/bi00334a014 3927973 (Pubitemid 15028717)
37. Fludarabine-induced immunosuppression is associated with inhibition of STAT-1 signaling. Frank DA, Mahaian S, Ritz J, Nat Med 1999 5 444 447 10.1038/7445 10202937 (Pubitemid 29180586)
38. Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer. Li R, You S, Hu Z, Chen ZG, Sica GL, Khuri FR, Curran WJ, Shin DM, Deng X, PLoS One 2013 8 74670 10.1371/journal.pone.0074670 24019973
39. The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis. Content J, de la Cuvellerie A, De Wit L, Vincent-Levy-Frebault V, Ooms J, De Bruyn J, Infect Immun 1991 59 3205 3212 1715324
40. Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Harth G, Lee BY, Wang J, Clemens DL, Horwitz MA, Infect Immun 1996 64 3038 3047 8757831 (Pubitemid 26256143)
41. Lysosomal acidification mechanisms. Mindell JA, Annu Rev Physiol 2012 74 69 86 10.1146/annurev-physiol-012110-142317 22335796
42. IL-6 inhibits IFN-γ induced autophagy in Mycobacterium tuberculosis H37Rv infected macrophages. Dutta RK, Kathania M, Raje M, Majumdar S, Int J Biochem Cell Biol 2012 44 942 954 10.1016/j.biocel.2012.02.021 22426116
43. Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection. Pitt JM, Stavropoulos E, Redford PS, Beebe AM, Bancroft GJ, Young DB, O'garra A, J Immunol 2012 189 4079 4087 10.4049/jimmunol.1201061 22972927
44. Modulation of virulence factors in Francisella tularensis determines human macrophage responses. Carlson PE, Carroll JA, O'Dee DM, Nau GJ, Microb Pathog 2007 42 204 214 10.1016/j.micpath.2007.02.001 17369012 (Pubitemid 46654701)
45. Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena. Zinchk V, Zinchuk O, Okada T, Acta Histochemica Et Cytochemica 2007 40 101 111 10.1267/ahc.07002 17898874 (Pubitemid 47416687)
46. The intracellular environment of human macrophages that produce nitric oxide promotes growth of mycobacteria. Jung JY, Madan-Lala R, Georgieva M, Rengarajan J, Sohaskey CD, Bange F-C, Robinson CM, Infect Immun 2013 81 3198 3209 10.1128/IAI.00611-13 23774601